Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer

This study has been completed.
Information provided by (Responsible Party):
Chugai Pharmaceutical Identifier:
First received: April 26, 2007
Last updated: April 25, 2012
Last verified: April 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2011
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)